-+ 0.00%
-+ 0.00%
-+ 0.00%

Canaccord Genuity Maintains Buy on Compass Pathways, Maintains $15 Price Target

Benzinga·08/01/2025 15:08:06
Listen to the news
Canaccord Genuity analyst Sumant Kulkarni maintains Compass Pathways (NASDAQ:CMPS) with a Buy and maintains $15 price target.